Eloxx Pharmaceuticals, Inc. (ELOX)
15.41
+0.40
(+2.66%)
USD |
OTCM |
Sep 02, 13:18
Eloxx Pharmaceuticals Research and Development Expense (TTM) : 6.647M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.647M |
| March 31, 2026 | 6.145M |
| June 30, 2025 | 7.974M |
| September 30, 2023 | 10.37M |
| June 30, 2023 | 14.00M |
| March 31, 2023 | 19.32M |
| December 31, 2022 | 23.73M |
| September 30, 2022 | 28.34M |
| June 30, 2022 | 28.67M |
| March 31, 2022 | 26.72M |
| December 31, 2021 | 22.90M |
| September 30, 2021 | 17.63M |
| June 30, 2021 | 15.65M |
| March 31, 2021 | 13.47M |
| December 31, 2020 | 13.95M |
| September 30, 2020 | 16.99M |
| June 30, 2020 | 20.56M |
| March 31, 2020 | 24.37M |
| December 31, 2019 | 25.84M |
| September 30, 2019 | 26.69M |
| June 30, 2019 | 25.30M |
| March 31, 2019 | 22.11M |
| December 31, 2018 | 20.11M |
| September 30, 2018 | 13.69M |
| June 30, 2018 | 8.390M |
| Date | Value |
|---|---|
| March 31, 2018 | 4.434M |
| June 30, 2017 | 0.6895M |
| March 31, 2017 | 0.9774M |
| December 31, 2016 | 1.418M |
| September 30, 2016 | 1.789M |
| June 30, 2016 | 2.090M |
| March 31, 2016 | 2.532M |
| December 31, 2015 | 2.210M |
| September 30, 2015 | 2.980M |
| June 30, 2015 | 4.530M |
| March 31, 2015 | 4.779M |
| December 31, 2014 | 5.418M |
| September 30, 2014 | 4.732M |
| June 30, 2014 | 3.339M |
| March 31, 2014 | 2.694M |
| December 31, 2013 | 2.312M |
| September 30, 2013 | 2.256M |
| June 30, 2013 | 2.042M |
| March 31, 2013 | 2.237M |
| December 31, 2012 | 2.285M |
| September 30, 2012 | 2.446M |
| June 30, 2012 | 2.566M |
| March 31, 2012 | 2.512M |
| December 31, 2011 | 2.771M |
| September 30, 2011 | 2.818M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Filana Therapeutics, Inc. | 15.66M |
| CorMedix, Inc. | 27.59M |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | 0.0082M |
| BioStem Technologies, Inc. | 5.309M |